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Background: With no effective screening tool, ovarian cancer survivors often suffer from unpleasant treatment-
related side effects that influence quality of life. Increased physical activity has been associated with lower 
depression scores in ovarian cancer survivors. However, to date, no randomized controlled trial assessing the effect 
of exercise on depression has been conducted in this population. The Women’s Activity and Lifestyle Study in 
Connecticut (WALC) was a randomized trial examining the impact of exercise vs. attention-control on quality of 
life, body composition, and cancer biomarkers in ovarian cancer survivors. This analysis examined the effect of 
exercise on depression scores. 
Methods: We enrolled 144 physically inactive (< 90 minutes per week of exercise) ovarian cancer survivors who 
had been diagnosed within the past 4 years and completed initial chemotherapy into a six-month randomized 
controlled trial. Women randomized to the exercise intervention arm (n = 74) received 25 weekly phone calls from a 
certified cancer exercise trainer and were counseled on increasing their physical activity to 150 minutes per week of 
home-based aerobic exercise. Women randomized to the attention-control arm (n = 70) also received 25 weekly 
phone calls to discuss relevant health topics. Depression symptomatology was measured via the Center for 
Epidemiologic Studies Depression Scale (CES-D) at baseline and six-months. Student’s t-test and generalized linear 
models were used to compare changes in depression from baseline to six-months between the two arms.  
Results: All baseline characteristics were similar between the two arms. Adherence to both the exercise intervention 
and attendance to the weekly calls was outstanding with women on the exercise intervention arm exercising an 
average of 166 minutes per week and >70% of women on both arms attending > 20 calls. At baseline 39 women 
(27%) had a CES-D score greater than 16, indicating depressive symptomatology. CES-D scores decreased in 
women on the exercise intervention arm by an average of 2.2 ± 7.0 points (17% decrease) compared to an increase 
of 0.4 ± 5.6 points (4% increase) in women randomized to the attention-control arm (p = 0.02). A dose-response 
inverse relation of exercise with CES-D score was also observed (p < 0.01). 
Conclusions: Ovarian cancer survivors are interested in and able to exercise at recommended levels, with exercise 
decreasing CES-D scores. Exercise above and beyond the attention participants received helped improve depression 
symptomatology. Exercise programs for ovarian cancer survivors should be implemented in an effort to improve 
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Background: With no effective screening tool, ovarian cancer survivors often suffer from unpleasant treatment-
related side effects that influence quality of life. Increased physical activity has been associated with lower 
depression scores in ovarian cancer survivors. However, to date, no randomized controlled trial assessing the effect 
of exercise on depression has been conducted in this population. The Women’s Activity and Lifestyle Study in 
Connecticut (WALC) was a randomized trial examining the impact of exercise vs. attention-control on quality of 
life, body composition, and cancer biomarkers in ovarian cancer survivors. This analysis examined the effect of 
exercise on depression scores. 
Methods: We enrolled 144 physically inactive (< 90 minutes per week of exercise) ovarian cancer survivors who 
had been diagnosed within the past 4 years and completed initial chemotherapy into a six-month randomized 
controlled trial. Women randomized to the exercise intervention arm (n = 74) received 25 weekly phone calls from a 
certified cancer exercise trainer and were counseled on increasing their physical activity to 150 minutes per week of 
home-based aerobic exercise. Women randomized to the attention-control arm (n = 70) also received 25 weekly 
phone calls to discuss relevant health topics. Depression symptomatology was measured via the Center for 
Epidemiologic Studies Depression Scale (CES-D) at baseline and six-months. Student’s t-test and generalized linear 
models were used to compare changes in depression from baseline to six-months between the two arms.  
Results: All baseline characteristics were similar between the two arms. Adherence to both the exercise intervention 
and attendance to the weekly calls was outstanding with women on the exercise intervention arm exercising an 
average of 166 minutes per week and >70% of women on both arms attending > 20 calls. At baseline 39 women 
(27%) had a CES-D score greater than 16, indicating depressive symptomatology. CES-D scores decreased in 
women on the exercise intervention arm by an average of 2.2 ± 7.0 points (17% decrease) compared to an increase 
of 0.4 ± 5.6 points (4% increase) in women randomized to the attention-control arm (p = 0.02). A dose-response 
inverse relation of exercise with CES-D score was also observed (p < 0.01). 
Conclusions: Ovarian cancer survivors are interested in and able to exercise at recommended levels, with exercise 
decreasing CES-D scores. Exercise above and beyond the attention participants received helped improve depression 
symptomatology. Exercise programs for ovarian cancer survivors should be implemented in an effort to improve 





In the United States ovarian cancer is the leading cause of death for cancers of the female reproductive 
system and the fifth leading cause of cancer-related death in women with over 21,000 incident cases and 14,000 
deaths due to ovarian cancer every year [1, 2]. There have been some biomedical advances with respect to 
developing effective therapies that increase length of survival, however, no effective screening test exists for early 
detection resulting in 61% of cases being detected at a distant stage (stage III/IV) [2]. This causes the standard 
treatment to be extremely invasive surgery (removal of ovaries, fallopian tubes, uterus, and omentum) and 
chemotherapy [2]. Such physically demanding treatment can have a dramatic impact on an individual’s overall well-
being and mental health both during and following treatment with frequent reports of cancer-related fatigue, 
peripheral neuropathy, and psychological distress [3]. Moreover, the high likelihood of recurrence (five-year 
survival ranges from 27% for distant cancer to 92% for localized cancer) associated with the aggressiveness of the 
cancer causes survivors to constantly address physical and psychological morbidities, resulting in negative health 
related effects such as increased depression and anxiety [2-6].  
Depression is one of the most prevalent mental disorders throughout the world, projected to be the second-
leading cause of disease burden by 2030 [7-9]. Prior research indicates that depression rates tend to be higher among 
cancer survivors than compared to the general population, with up to 50% of cancer patients having 
symptomatology that meets the criteria for a clinical diagnosis [10-12]. Furthermore, depressive symptoms can have 
detrimental effects on quality of life, motivation, and physical functioning in cancer patients and survivors [10, 13]. 
Additionally, anxiety and depression rates tend to be higher in ovarian cancer patients as compared to cohorts of 
other cancers [4, 14].  
Due to the physical and mental benefits of exercise, a growing number of studies have examined the 
associations between physical activity and improved cancer outcomes, particularly cancer-related fatigue and health-
related quality of life [15]. Small intervention and cross-sectional studies have shown that exercise and education 
can improve quality of life in cancer patients and can help increase overall survival [16-19]. In observational and 
cross-sectional studies, exercise has been associated with better symptoms, well-being, and lower depression scores 
among individuals on treatment for ovarian and other cancers [20-22]. Cross-sectional research supports that 
meeting physical activity recommendations is associated with better sleep, psychosocial function, health-related 
quality of life, and lower self-reported depression, anxiety, and cancer-related fatigue among ovarian cancer 
survivors [3, 18, 23].  
While exercise has been shown to result in positive health outcomes, no large-scale randomized-controlled 
trial assessing the effect of exercise on depression in ovarian cancer survivors has been conducted. The Women’s 
Activity and Lifestyle Study in Connecticut (WALC) study was a randomized trial examining the impact of exercise 
vs. attention-control on quality of life, body composition, and cancer biomarkers. The purpose of this analysis was to 
examine the effect of exercise on depression symptomatology in ovarian cancer survivors participating in WALC. 
As overall well-being and quality of life are compromised in ovarian cancer patients, we hypothesize that exercise 






Women with ovarian cancer diagnosed at Connecticut based hospitals were identified and if eligible, 
invited to participate in the study. Additionally eligible women throughout the US who self-referred for the study 
were recruited. Participants were randomized between March 9, 2010 and March 20, 2014. Women found to be 
eligible after screening and baseline assessments were randomized to a six-month home-based aerobic exercise 
intervention or an attention-control arm. We enrolled 144 women into the WALC study. 
Study Sites 
There were three study sites where in-person visits and physical exams were performed. All Connecticut 
based patients were seen at the Smilow Cancer Hospital at Yale New Haven (WALC-CT). Women were also seen at 
the Dana Farber Cancer Institute (WALC-DF) and Geisinger Health Systems (WALC-G). Additionally, a subset of 
the study population (self-referred individuals) completed the study remotely and never came to a study site 
(WALC-N).  
Recruitment and Study Visits  
The Rapid Case Ascertainment Shared Resource of the Yale Cancer Center (RCA), a field arm of the 
Connecticut Tumor Registry, was used to identify women with an ovarian cancer diagnosis from all Connecticut-
based hospitals. After obtaining physician consent to contact their patient(s), a study recruitment letter was mailed to 
each woman. Within a week of mailing, each woman was telephoned to assess interest and determine eligibility. 
Women that were English speaking, physically inactive (< 90 minutes per week of exercise), between the ages of 
18-75, diagnosed with ovarian cancer between January 2007 and May 2013, had completed chemotherapy at least 
one-month prior to randomization, and had physician consent to start an exercise program met eligibility criteria.  
Participants considered to be eligible through the initial screening communication were asked to come to 
their respective study site for a baseline visit. At this visit the women completed questionnaires on demographics, 
clinical characteristics and medical history, health-related quality of life (including CES-D), physical activity, and 
they underwent a physical exam (height/weight). Upon completion of this visit, women were randomized to a six-
month home-based aerobic exercise intervention program or an attention-control health-education program. 
Questionnaires and study measurements were also completed at the six-month study visit, with the quality of life 
assessment also conducted by mail at 3-months.  
Additionally, women from throughout the US (WALC-N) who inquired about the study upon learning 
about it through support groups, interested physicians, or survivor blogs were screened for eligibility and if eligible 
invited to participate in the study.  For these participants, all baseline and follow up assessments were conducted by 
mail or over the telephone.   
The Connecticut Department of Public Health, the Yale Human Investigation Committee, and all associated 
hospital institutional review boards approved this study. 
Measures 
 At the baseline and six-month study visits, participants completed several questionnaires. The self-reported 
socio-demographic indicator variables ascertained at baseline included current age, race/ethnicity, education level, 
employment status, and marital status. Additionally, we collected information on the participant’s family history of 
ovarian cancer, cancer stage, time since diagnosis, history of chemotherapy treatment, recurrence, and depression. 
Physical activity within the previous six months was assessed using the Modifiable Physical Activity Questionnaire, 
which ascertained the duration and frequency of participation for 20 recreational activities [24]. Height and weight 
were measured using standard procedures (weight in light clothing and without shoes was measured using an 
electronic scale with measurements rounded up to the nearest 0.1 kg and height without shoes was measured using a 
stadiometer with measurements rounded up to the nearest 0.5 cm). The participant’s treating physician verified the 
reported treatment information through an additional mailed questionnaire.  
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 The main study outcome was depression symptomatology assessed using the 20-item Center for 
Epidemiological Studies Depression Scale (CES-D), a screening tool recommended by the U.S. Preventive Services 
Task Force [25, 26]. This measure has been used in populations with diverse socioeconomic and demographic 
characteristics and has been recognized as a valid and reliable measure of depressive symptomatology with good 
internal consistency, high alpha coefficients, and adequate test-retest reliability among cancer patients [26-29]. 
Using a Likert scale from 0 (never or rarely) to 3 (most of the time or all of the time) with reverse coding of the four 
items that assess positive symptoms, the tool measures symptoms within the past week. Summed scores range from 
0-60 whereby higher scores represent increased levels of depressive symptomology. Using the established and 
validated criteria, participants were classified as being above or below the cutoff for significant depression 
symptomatology (summed scores > 16 or < 16 respectively) [27, 30].  
Interventions 
The six-month exercise intervention consisted of a home-based moderate-intensity aerobic exercise 
program facilitated by weekly phone calls from an American College of Sports Medicine certified cancer exercise 
trainer and health educator. Women were counseled on increasing their physical activity to 150 minutes per week of 
moderate-intensity aerobic exercise. Adherence was primarily measured using Daily Activity Logs where women 
self-recorded the type, duration, and intensity (based on heart rate monitors) of exercise. Women also reported their 
levels of exercise during the weekly telephone calls with the trainer. Using a 26-chapter book developed for the 
study, the trainer was able to provide weekly counseling and support over the telephone, discuss various educational 
topics on exercise, and review a weekly ovarian cancer health-education topic to increase participant exercise levels. 
The attention-control health-education arm also received weekly phone calls from the certified cancer exercise 
trainer during which the ovarian cancer health-education topics were discussed.  
Statistical Analysis 
 Descriptive statistics were used to describe the study population based on socio-demographic and clinically 
relevant indicators according to study randomization. Generalized linear models (GLM) comparing the women 
randomized to the exercise intervention arm and women randomized to the attention-control arm were used to 
analyze the impact of physical activity on depressive symptomology. Our analysis was performed using the intent-
to-treat principle in order to assess significant differences in CES-D score between the baseline and six-month study 
visits. For those women who did not complete the six-month assessment of depressive symptomatology, the change 
in CES-D was imputed as 0. Potential covariates included baseline CES-D score, cancer stage, age, time since 
diagnosis, history of recurrence prior to enrollment, and recurrence of cancer during the study period.  
 To explore the effect of the amount of exercise on depressive symptomatology, a sub-group analysis among 
women randomized to the exercise intervention arm was performed. We examined the impact of exercise dose on 
depressive symptomatology by comparing the women who self-reported participating in an average of at least the 
recommended 150 minutes of exercise per week and those that did not. Among all participants, we examined the 
impact of attendance to the weekly telephone calls on depressive symptomatology.  Lastly, we performed a stratified 
analysis to evaluate effect modification by depressive symptomatology at baseline, cancer stage, age, cancer 
recurrence prior to enrollment and during the study period, attendance to weekly telephone calls, and exercise 
adherence. All statistical analysis was conducted using SAS, Version 9.3 (SAS, Cary, NC) with a two-sided 0.05 






 A total of 767 ovarian cancer survivors were identified within Connecticut between February 2010 and 
September 2013 (Figure 1). However, 83 women were found to be ineligible.  Each survivor’s physician was 
contacted for consent to contact and consent to exercise. Of the remaining 684 patients, recruitment invitation letters 
were mailed to 545 women (80%) for whom we had received consent. Out of these women, 461 were screened by 
telephone. An additional 49 women self-referred or were recruited by physicians, resulting in a total of 510 women 
who completed screening. Of these women, 235 were ineligible and 131 were not interested, which resulted in 144 
women being randomized to the study (exercise intervention arm n = 74; attention-control arm n = 70). The majority 
(66%) of the study population was seen at the Yale site (n = 95).  Approximately 5% and 6% of the study came from 
Dana Farber Cancer Institute (n = 7) and Geisinger Health Systems (n = 8), respectively. The remaining 24% of the 
study population were self-referred (n = 34) (Table 1).   
Baseline Characteristics 
 On average, participants at enrollment were 57.3 ± 8.6 years old, 1.7 ± 1.0 years post-diagnosis, had a BMI 
of 29.0 ± 7.0 kg/m2, and exercised for 28.3 ± 41.6 minutes per week. The majority of the study population were non-
Hispanic white (98%), married or living with a partner (73%), had graduated college or had an advanced degree 
(56%), were diagnosed with stage III/IV disease (55%), and had received chemotherapy prior to enrollment (93%) 
(Table 1). At enrollment, 39 women (27%) had experienced clinically significant depressive symptomology within 
the past week based on a CES-D score > 16. Of these women, only 21 (54%) also had a self-reported history of 
depression. The average baseline CES-D score was 12.7 ± 10.5 on the exercise intervention arm, 10.8 ± 9.8 on the 
attention-control arm, and ranged from 0-47 (p = 0.27) (Table 3). All characteristics were similar for both arms (p > 
0.05).  
Adherence to the Intervention  
 Adherence to both the exercise intervention and attendance to the weekly calls was outstanding (Table 2). 
For women on the exercise intervention arm, Daily Activity and Call Logs were used to monitor weekly progress 
towards the weekly exercise goal (150 minutes). During the six-month intervention, women participated in an 
average of 166.0 ± 66.1 minutes per week (111% of the goal) and 65% were able to exercise at least 150 minutes per 
week. Furthermore, over 70% of women on both arms attended > 20 calls (exercise intervention arm = 80%; 
attention-control arm = 74%).  
Change in Depression Symptomatology  
 Table 3 shows the baseline CES-D score, the change in CES-D score over the six-month intervention 
period, and the number of individuals with depressive symptomology based on CES-D. There was no significant 
difference between the two arms with respect to baseline CES-D scores (p = 0.27). Over the 6-month intervention 
period, a 17% decrease and a 4% increase in scores were observed among women randomized to the exercise 
intervention arm and attention-control arm, respectively. This represents a statistically significant difference 
between the arms with respect to the change in CES-D score (p = 0.02). There were no significant differences 
observed between the two arms with respect to the number of women who experienced depressive symptomatology 
within the past week at baseline (exercise intervention arm = 31%; attention-control arm = 23%; p = 0.27) or at six-
months (exercise intervention arm = 17%; attention-control arm = 15%; p = 0.85). Of the 18 women with a 
clinically significant CES-D (score > 16) at the six-month follow-up, 11 also had a clinically significant CES-D at 
baseline (exercise intervention arm n = 7; attention-control arm n = 4). Of these 11 individuals, six had a decrease in 
score (exercise intervention arm n = 5; attention-control arm n = 1). Thirty-two women (22%) did not complete the 
six-month CES-D questionnaire. The majority (63%) of these individuals did not have a clinically significant CES-
D score at baseline (10 women from each study arm). Of the remaining 12 non-compliers who had a clinically 
significant CES-D score at baseline, only four were randomized to the exercise intervention arm. No statistically 
significant difference between the arms with respect to non-compliance was observed (p = 0.36).         
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Stratified Analysis  
 Table 4 highlights the results of the stratified analysis examining the change in CES-D. After adjusting for 
site, baseline CES-D score, and randomization arm, women who adhered to the exercise intervention goal of 150 
minutes per week experienced a highly statistically significant 3.4 point decrease in CES-D score (p < 0.01). In 
comparison, women who reported exercising < 150 minutes per week experienced a 0.7 point decrease in CES-D 
score and this change was not statistically significant (p = 0.93). Looking at the women with early-stage (I/II) 
diagnoses, women on the exercise intervention arm experienced a borderline significant greater decrease in CES-D 
as compared to women on the attention-control arm (p = 0.06). Additionally, for the women who did not have a 
recurrence prior to enrollment, women on the exercise intervention arm experienced a significantly greater decrease 
in CES-D as compared to women on the attention-control arm (p = 0.03). Similarly, although statistically 
insignificant, women on the exercise intervention arm who had a recurrence during the six-month study period also 
experienced a greater decrease in CES-D score as compared to women on the attention-control arm (p = 0.21). 
Finally, after adjusting for study site and randomization arm, individuals on the exercise intervention arm with 
baseline CES-D scores > 16 experienced a greater decrease in CES-D score as compared to those individuals on the 
attention-control arm, however, this was not statistically significant (p = 0.12). Although we conducted stratified 
analyses to evaluate effect modification by baseline CES-D score, disease stage, age, recurrence status (both prior to 
enrollment and during the study period), exercise adherence, and attendance at weekly telephone calls, no significant 






 We found that a moderate-intensity home-based aerobic exercise program improved depressive 
symptomatology indicated by a reduction in mean CES-D scores in ovarian cancer survivors. A dose-response 
inverse relation of exercise with CES-D score was observed, with increased exercise (> 150 minutes per week) 
being associated with more robust decreases in CES-D. Similar positive associations between physical activity and 
health-related quality of life or depression have been shown through cross-sectional and prospective studies 
conducted in the general population and among people with depression [9, 31, 32]. Additionally, a systematic 
review of randomized and controlled clinical trials found that physical exercise during and after cancer treatment has 
positive effects on psychological well-being and overall quality of life [33]. Furthermore, as seen in this study, 
greater amounts of physical activity are generally associated with an increased reduction of depression symptoms 
[34]. 
 While exercise is considered to be an effective antidepressant, the exact mechanism of action is unknown 
[35, 36]. However, it could relate to various physiologic or psychosocial mechanisms. For example, the monoamine 
hypothesis states that exercise increases the availability of neurotransmitters that are usually diminished among 
depressed individuals (e.g. serotonin, dopamine, and norepinephrine) [37].  While these neurotransmitters have been 
shown to increase peripherally, it is unclear whether neurotransmitter levels increase in the brain [37]. Alternatively, 
exercise could decrease depressive symptomatology by providing a means for social support. However, as both 
study arms received support and counseling over the phone, the decreased rates of depressive symptomatology 
among women on the exercise intervention arm could be due to exercise reducing levels of fatigue making the 
completion of daily activities easier. Regardless of the mechanism, meta-analytic studies have shown that the effect 
size of exercise on depression is large (ranging from -0.72 to -1.4) and is equally effective for men and women of 
various ages and with varying depression levels [35]. As a final caveat, prior research has found that home-based, 
unsupervised exercise is associated with increased depressive symptoms [35]. Although we were able to see a 
reduction in depressive symptomatology using a home-based exercise regime, future studies should assess if larger 
effects can be seen through supervised exercise programs.  
   Given the population-based recruitment, randomized design with an attention-control arm, large sample 
size, and six-month intervention period, to our knowledge this is the strongest methodological study that examines 
the role of exercise in women who have been diagnosed with ovarian cancer. A potential weakness in our design 
was the reliance on self-report for physical activity and depressive symptomatology rather than using more objective 
measures (i.e. accelerometers for physical activity or a clinical evaluation for depression). However, recall and 
responder bias are likely minimized due to the prospective design, daily recording of exercise for those women 
randomized to the exercise intervention arm, and weekly follow-up calls with the exercise trainer/health educator.  
Despite the fact that all women who enrolled had completed treatment, 16% of the study population had 
experienced a recurrence prior to enrollment and 24% of the study population experienced a recurrence during the 
six-month study. This, in conjunction with approximately 55% of the study population being diagnosed with distant 
(stage III/IV) disease, emphasizes the aggressiveness of the cancer. Looking specifically at CES-D, baseline scores 
in our study population were comparable to the CES-D scores seen in other cancer-patient populations of similar age 
but tended to be higher than those scores previously reported among healthy-comparison groups [4, 29]. A 
convenience sample of outpatient epithelial ovarian cancer patients found the mean CES-D score to be 10.2 [4]. 
Additionally, women scheduled to undergo radiotherapy, chemotherapy, or bone marrow transplantation (BMT) for 
breast cancer had an average CES-D score of 10.9 (prior to treatment initiation) and an average CES-D score of 12.8 
(while on treatment) [29]. In comparison, the mean CES-D score for the healthy comparison group (women with 
similar demographic characteristics) that was used in the aforementioned breast cancer study was approximately 8 at 
both time-points [29]. Furthermore, a greater proportion of women in our study had CES-D scores above the clinical 
threshold warranting a full clinical evaluation as compared to those typically seen in the general population [26, 38]. 
In our study, 27% of participants at baseline met the CES-D cutoff criteria for a clinical evaluation for depression 
(CES-D scores > 16). This is consistent with what was observed in the convenience sample of epithelial ovarian 
cancer patients whereby 21% of participants met the cutoff criteria [4]. However, prior estimates using CES-D 
within the general population have shown the prevalence of depression to be around 15-16% [38]. 
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Even though we consider our study’s sample size to be a strength, our study was not powered for stratified 
analyses. However, the current trends highlight that exercise rather than the attention-control was more effective in 
reducing CES-D scores among women who were diagnosed with either localized (stage I/II) or distant cancer (stage 
III/IV) or had a recurrence during the study. Additionally, given that exercise also appears to reduce CES-D scores 
among women of any age and among those with a clinically significant CES-D at baseline, the use of exercise has 
many clinical implications.  
To summarize, depressive symptoms in this patient population is a concern that has been defined but rarely 
addressed. Our results indicate that not only is a six-month home-based exercise intervention in ovarian cancer 
survivors feasible but it is also able to improve depressive symptomatology as measured by CES-D. While women 
randomized to the exercise intervention arm had an overall decrease in CES-D score, the effect was much stronger 
among those women who met the weekly exercise goal (150 minutes per week). The limited exclusion criteria and 
the population-based cohort allowed us to capture a comprehensive sample of inactive ovarian cancer survivors, 
making the results generalizable to the larger population of ovarian cancer survivors. Furthermore, the nature of the 
intervention (home-based, moderate-intensity, aerobic exercise program) enables this type of exercise program to be 
easily adapted and disseminated. Thus, our findings can be used to inform future studies or programs dedicated to 
improving the lives of ovarian cancer survivors.  
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TABLE 1: Description of the Sample at Baseline by Study Arma  
  Total Study 
Population 
(N = 144)b 




 (N = 74)b 
Attention 
Control 
 (N = 70)b pc 
Study Site    0.94 
     WALC-CT 95 (66.0) 50 (67.6) 45 (64.3)  
     WALC-N 34 (23.6) 16 (21.6) 18 (25.7)  
     WALC-G 8 (5.6) 4 (5.4)     4 (5.7)  
     WALC-DF 7 (4.9) 4 (5.4) 3 (4.3)  
Age (years) 57.3 ± 8.6 57.3 ± 8.8 57.4 ± 8.5 0.91 
Race/ethnicity    0.07 
     Non-Hispanic white 141 (97.9) 74 (100.0) 67 (95.7)  
     Other   3 (2.1) 0 (0.0) 3 (4.3)  
Education Level    0.60 
     No GED or Equivalent 4 (2.8) 3 (4.1) 1 (1.4)  
     GED and Some College/Associates 60 (41.7) 32 (43.2) 28 (40.0)  
     College Graduate or Advanced Degree 80 (55.6) 39 (52.7) 41 (58.6)  
Employment Status    0.46 
     Unemployed/Retired 69 (48.3) 34 (46.0) 35 (50.7)  
     Employed Part Time (<35 hrs/wk) 29 (20.3) 18 (24.3) 11 (15.9)  
     Employed Full Time (>35 hrs/wk) 45 (31.5) 22 (29.7) 23 (33.3)  
Marital Status    0.24 
     Single 15 (10.4) 8 (10.8) 7 (10.0)  
     Divorced, Separated, or Widowed 24 (16.7) 16 (21.6) 8 (11.4)  
     Married or Living with Partner 105 (72.9) 50 (67.6) 55 (78.6)  
Family History of Ovarian Cancer    0.41 
     Yes 18 (12.7) 11 (14.9) 7 (10.3)  
     No 124 (87.3) 63 (85.1) 61 (89.7)  
Cancer Stage at Diagnosis    0.26 
     Stage I 34 (23.6) 21 (28.4) 13 (18.6)  
     Stage II 30 (20.8) 11 (14.9) 19 (27.1)  
     Stage III 58 (40.3) 31 (41.9) 27 (38.6)  
     Stage IV 21 (14.6) 10 (13.5) 11 (15.7)  
     Unknown   1 (0.70) 1 (1.4) 0 (0.0)  
Time Since Diagnosis (years) 1.7 ± 1.0 1.7 ± 0.9 1.7 ± 1.1 0.72 
Chemotherapy Prior to Enrollment    0.93 
     Yes 134 (93.1) 69 (93.2) 65 (92.9)  
     No 10 (6.9) 5 (6.8) 5 (7.1)  
Cancer Recurrence Prior to Enrollment    0.59 
     Yes  23 (16.0) 13 (17.6) 10 (14.3)  
     No/Unknown 121 (84.0) 61 (82.4) 60 (85.7)  
Body mass index (kg/m2)  29.0 ± 7.0 29.0 ± 7.2 29.1 ± 6.8 0.91 
Physical Activity (min/wk)  28.3 ± 41.6 26.0 ± 44.2 30.8 ± 38.9 0.50 
Self-Reported History of Depression     0.86 
     Yes   38 (26.4) 20 (27.0) 18 (25.7)  
     No 106 (73.6) 54 (73.0) 52 (74.3)  
a Table values are mean ± SD for continuous variables and n (column %) for categorical variables. 
b Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 




TABLE 2: Adherence to Interventiona 
  









(N = 70) 
 
 
Average Minutes/Week of Exercise 166.0 ± 66.1 N/A   
% of Goal (150 Min/Wk) 110.7% N/A  
% Participants Adhering to    
≥ 150 Min/week (100%) 64.9% N/A  
≥ 120 Min/week (80%) 83.8% N/A  
≥ 90 Min/ week (60%) 91.9% N/A  
≥ 60 Min/ week (40%) 91.9% N/A  
≥ 30 Min/ week (20%) 98.6% N/A  
< 30 Min/ week (0%) 100.0% N/A  
  




 Intervention Arm 









Average Attendance to Calls 21.7 ± 5.5 20.4 ± 5.6 0.18   
% of Goal (25 Calls) 86.7% 81.7%    
% Participants Adhering to      
25 Calls (100%) 47.3% 19.1%    
≥ 20 calls (80%) 79.7% 73.5%    
≥ 15 calls (60%) 89.2% 86.8%    
≥ 10 calls (40%) 94.6% 94.1%    
≥ 5 calls (20%) 98.6% 97.1%    
≥ 0 calls (0%) 100.0% 100.0%    
a Table values are mean ± SD for average values and proportions for adherence between Baseline and 6 Months. 





TABLE 3: Depression Symptomatology by Arma 




 (N = 74)b 
Attention 
Control 
 (N = 70)b pc 
Baseline CES-D Score (Range: 0-60)  12.7 ± 10.5 10.8 ± 9.8 0.27 
     Range (0 – 47) (0 – 45)  
Unadjusted Change in CES-D Score -2.2 ± 7.0 0.4 ± 5.8 0.02 
     % Change -17.3 3.7  
    
Baseline Depression Symptomatology    0.27 
     CES-D > 16 23 (31.1) 16 (22.9)  
     CES-D < 16 51 (68.9) 54 (77.1)  
Six-Month Depression Symptomatology   0.85 
     CES-D > 16 10 (16.7) 8 (15.4)  
     CES-D < 16 50 (83.3) 44 (84.6)  
a Table values are mean ± SD for continuous variables and n (column %) for categorical variables. 
b Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 






TABLE 4: Change in CES-D Stratified by Study Variablesa 
 
a Numbers are Change in CES-D using least-square mean (SE) 
b Model controls for study arm and study site  
c Model controls for study arm, baseline depression CES-D score, and study site 
  
     
 




Change in CES-D 






BL Depression Symptomatologyb     
     CES-D < 16 (n = 105) 0.2 (0.7)  1.5 (0.6) 0.18 0.57 




Cancer Stagec     
     Stage I/II (n = 64) -3.0 (1.2) 0.2 (1.2) 0.06 0.22 




Age     
     < 57 years  (n = 69) -2.2 (1.0) -0.1 (1.1) 0.19 0.92 




Recurrence Prior to Enrollmentc     
     Yes (n = 23) -0.9 (1.5) -1.5 (1.7) 0.79 0.35 




Recurrence on Studyc     
     Yes (n = 34) -1.0 (1.5) 1.4 (1.1) 0.21 0.88 




Call Attendancec     
     < 20 Calls (n = 33) -1.5 (0.9) 0.3 (0.8) 0.17 0.86 




Exercise Adherencec     
     < 150 min/wk (n = 26) -0.7 (0.9) N/A 0.93 N/A 
     > 150 min/wk (n = 48) -3.4 (0.8) N/A < 0.01  
